K Csép1, E Szigeti1, M Vitai2, L Korányi2. 1. University of Medicine and Pharmacy, Department of Genetics, Tg. Mureş, Romania. 2. Drug Research Center, Balatonfüred, Hungary.
Abstract
BACKGROUND: The peroxisome proliferator-activated receptor-γ co-activator 1-α (PPARGC1A), a key transcription factor involved in the control of metabolism and energy homeostasis, is an important biological and positional candidate of the metabolic syndrome. Association studies of its polymorphisms, however, yielded inconsistent sometimes conflicting results, pointing to important ethnic differences, which call for replication in various populations. OBJECTIVE: In order to study its most common - potentially functional - polymorphism Gly482Ser (rs8192678), we carried out a case-control study in a central Romanian population. MATERIAL AND METHODS: Two hundred and ninety six patients affected by the metabolic syndrome diagnosed according to the International Diabetes Federation proposed criteria and 166 middle-aged control subjects have been investigated. Genotyping was done by PCR-RFLP, using the restriction enzyme MspI. RESULTS: While the G(Gly)/A(Ser) allele frequencies (66.89/33.11 vs. 71.68/28.31 %) and GG/GA/AA genotype distribution (45.27-43.24-11.48 vs. 54.21-34.93-10.84 %) differed in the metabolic syndrome and control group, the risk of developing the metabolic syndrome did not reach the limit of statistical significance (OR=1.43; p=0.06, CI 95%: 0.97-2.09). Metabolic parameters in the two study groups did not show significant differences according to the genotype (p>0.05). CONCLUSION: rs8192678 could be a functional polymorphism contributing to the development of the metabolic syndrome, but probably its effect is minor, and might depend on gene-gene and gene-environment interactions. Clarification of very small effects would require larger sample sizes.
BACKGROUND: The peroxisome proliferator-activated receptor-γ co-activator 1-α (PPARGC1A), a key transcription factor involved in the control of metabolism and energy homeostasis, is an important biological and positional candidate of the metabolic syndrome. Association studies of its polymorphisms, however, yielded inconsistent sometimes conflicting results, pointing to important ethnic differences, which call for replication in various populations. OBJECTIVE: In order to study its most common - potentially functional - polymorphism Gly482Ser (rs8192678), we carried out a case-control study in a central Romanian population. MATERIAL AND METHODS: Two hundred and ninety six patients affected by the metabolic syndrome diagnosed according to the International Diabetes Federation proposed criteria and 166 middle-aged control subjects have been investigated. Genotyping was done by PCR-RFLP, using the restriction enzyme MspI. RESULTS: While the G(Gly)/A(Ser) allele frequencies (66.89/33.11 vs. 71.68/28.31 %) and GG/GA/AA genotype distribution (45.27-43.24-11.48 vs. 54.21-34.93-10.84 %) differed in the metabolic syndrome and control group, the risk of developing the metabolic syndrome did not reach the limit of statistical significance (OR=1.43; p=0.06, CI 95%: 0.97-2.09). Metabolic parameters in the two study groups did not show significant differences according to the genotype (p>0.05). CONCLUSION: rs8192678 could be a functional polymorphism contributing to the development of the metabolic syndrome, but probably its effect is minor, and might depend on gene-gene and gene-environment interactions. Clarification of very small effects would require larger sample sizes.
Authors: Paul I W de Bakker; Roman Yelensky; Itsik Pe'er; Stacey B Gabriel; Mark J Daly; David Altshuler Journal: Nat Genet Date: 2005-10-23 Impact factor: 38.330
Authors: Harald Esterbauer; Hannes Oberkofler; Veronika Linnemayr; Bernhard Iglseder; Margot Hedegger; Peter Wolfsgruber; Bernhard Paulweber; Gerd Fastner; Franz Krempler; Wolfgang Patsch Journal: Diabetes Date: 2002-04 Impact factor: 9.461
Authors: Hannes Oberkofler; Bertram Hölzl; Harald Esterbauer; Mingqiang Xie; Bernhard Iglseder; Franz Krempler; Bernhard Paulweber; Wolfgang Patsch Journal: Hypertension Date: 2003-02 Impact factor: 10.190
Authors: M Stumvoll; A Fritsche; L M t'Hart; J Machann; C Thamer; O Tschritter; T W Van Haeften; S Jacob; J M Dekker; J A Maassen; F Machicao; F Schick; R J Heine; H Häring Journal: Exp Clin Endocrinol Diabetes Date: 2004-05 Impact factor: 2.949
Authors: Rector Arya; Ravindranath Duggirala; Christopher P Jenkinson; Laura Almasy; John Blangero; Peter O'Connell; Michael P Stern Journal: Am J Hum Genet Date: 2004-01-20 Impact factor: 11.025
Authors: Teresa C Leone; John J Lehman; Brian N Finck; Paul J Schaeffer; Adam R Wende; Sihem Boudina; Michael Courtois; David F Wozniak; Nandakumar Sambandam; Carlos Bernal-Mizrachi; Zhouji Chen; John O Holloszy; Denis M Medeiros; Robert E Schmidt; Jeffrey E Saffitz; E Dale Abel; Clay F Semenkovich; Daniel P Kelly Journal: PLoS Biol Date: 2005-03-15 Impact factor: 8.029
Authors: Adrián Montes-de-Oca-García; Juan Corral-Pérez; Daniel Velázquez-Díaz; Alejandro Perez-Bey; María Rebollo-Ramos; Alberto Marín-Galindo; Félix Gómez-Gallego; Maria Calderon-Dominguez; Cristina Casals; Jesús G Ponce-González Journal: Front Physiol Date: 2022-07-22 Impact factor: 4.755